HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Aysegul A Sahin Selected Research
Aysegul A Sahin Research Topics
Disease
110
Breast Neoplasms (Breast Cancer)
09/2022 - 01/2002
86
Neoplasms (Cancer)
09/2022 - 01/2002
21
Neoplasm Metastasis (Metastasis)
10/2019 - 05/2002
11
Carcinoma (Carcinomatosis)
09/2022 - 01/2002
10
Pathologic Complete Response
02/2017 - 06/2005
9
Triple Negative Breast Neoplasms
04/2021 - 01/2013
5
Carcinogenesis
01/2019 - 08/2002
4
Noninfiltrating Intraductal Carcinoma (DCIS)
09/2015 - 06/2002
3
Lobular Carcinoma
11/2021 - 01/2002
3
Lymphatic Metastasis
10/2018 - 04/2009
3
Genetic Predisposition to Disease (Genetic Predisposition)
04/2013 - 02/2002
2
Adenocarcinoma
12/2016 - 06/2005
2
Brain Neoplasms (Brain Tumor)
05/2015 - 09/2013
2
Inflammation (Inflammations)
04/2013 - 08/2007
2
Neoplasm Micrometastasis
06/2009 - 09/2003
2
Inflammatory Breast Neoplasms
10/2008 - 07/2007
2
Margins of Excision
10/2008 - 07/2005
2
Disease Progression
11/2004 - 05/2004
1
Extramammary Paget Disease (Paget Disease, Extramammary)
05/2019
Drug/Important Bio-Agent (IBA)
21
Proteins (Proteins, Gene)
FDA Link
12/2016 - 03/2002
18
Estrogen Receptors
IBA
01/2022 - 04/2002
13
Biomarkers (Surrogate Marker)
IBA
04/2021 - 06/2002
11
Trastuzumab (Herceptin)
FDA Link
11/2018 - 08/2003
10
Progesterone Receptors (Progesterone Receptor)
IBA
01/2022 - 04/2002
9
Messenger RNA (mRNA)
IBA
01/2021 - 03/2002
9
Hormones (Hormone)
IBA
10/2018 - 01/2004
9
Doxorubicin (Adriamycin)
FDA Link
Generic
03/2010 - 06/2002
7
Cyclophosphamide (Cytoxan)
FDA Link
Generic
03/2010 - 06/2002
7
Fluorouracil (Carac)
FDA Link
Generic
03/2010 - 06/2002
6
ErbB Receptors (EGF Receptor)
IBA
11/2021 - 05/2003
6
human ERBB2 protein
IBA
11/2021 - 06/2005
6
Ligands
IBA
05/2019 - 03/2002
6
Paclitaxel (Taxol)
FDA Link
Generic
03/2015 - 03/2003
5
Pharmaceutical Preparations
IBA
12/2018 - 02/2002
5
Epidermal Growth Factor (EGF)
IBA
12/2018 - 03/2002
5
Paraffin
IBA
10/2016 - 09/2003
5
Estrogens (Estrogen)
FDA Link
01/2016 - 03/2002
4
Phosphotransferases (Kinase)
IBA
04/2021 - 12/2003
4
Cytokines
IBA
12/2016 - 05/2002
4
Cyclin D1
IBA
12/2016 - 09/2003
4
Tamoxifen
FDA Link
Generic
09/2014 - 02/2003
4
Anthracyclines
IBA
05/2012 - 06/2002
4
Docetaxel (Taxotere)
FDA Link
05/2012 - 01/2003
3
Phenobarbital (Luminal)
FDA Link
09/2022 - 10/2016
3
Cyclin E
IBA
04/2021 - 01/2016
3
Tumor Biomarkers (Tumor Markers)
IBA
01/2021 - 10/2002
3
Peptides (Polypeptides)
IBA
01/2019 - 05/2002
3
Formaldehyde (Formol)
FDA Link
10/2016 - 09/2003
3
Biological Products
IBA
06/2009 - 10/2002
3
Transcription Factors (Transcription Factor)
IBA
12/2005 - 08/2003
3
NF-kappa B (NF-kB)
IBA
12/2005 - 11/2003
3
DNA Adducts
IBA
09/2003 - 02/2002
2
Immune Checkpoint Inhibitors
IBA
05/2019 - 01/2019
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
12/2016 - 08/2007
2
RNA (Ribonucleic Acid)
IBA
09/2015 - 12/2002
2
Indicators and Reagents (Reagents)
IBA
10/2014 - 01/2004
2
Hematoxylin (Haematoxylon)
IBA
10/2014 - 04/2005
2
Eosine Yellowish-(YS) (Eosin)
IBA
10/2014 - 04/2005
2
src-Family Kinases
IBA
09/2013 - 08/2005
2
DNA (Deoxyribonucleic Acid)
IBA
04/2013 - 01/2004
2
Estrogen Receptor alpha
IBA
05/2010 - 03/2003
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
08/2007 - 08/2002
2
Epirubicin (Ellence)
FDA Link
Generic
01/2007 - 06/2005
2
Protein Glutamine gamma Glutamyltransferase 2
IBA
09/2005 - 12/2004
2
Complementary DNA (cDNA)
IBA
09/2005 - 05/2004
2
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
05/2005 - 12/2002
2
Carrier Proteins (Binding Protein)
IBA
11/2003 - 03/2002
2
Neuregulin-1 (Neuregulin 1)
IBA
05/2003 - 03/2002
2
histidine-rich proteins
IBA
05/2003 - 03/2002
2
Carcinogens
IBA
08/2002 - 02/2002
2
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
08/2002 - 03/2002
1
Granzymes (Granzyme)
IBA
01/2022
1
Cytotoxins (Cytolysins)
IBA
09/2021
1
dinutuximab
IBA
01/2021
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
10/2019
1
Nucleic Acids
IBA
01/2019
1
safingol (sphinganine)
IBA
01/2019
1
Long Noncoding RNA
IBA
01/2019
1
Ligases (Synthetase)
IBA
01/2019
1
sphingosine kinase
IBA
01/2019
1
Histones (Histone)
IBA
01/2019
1
Antigens
IBA
01/2019
1
Bortezomib (Velcade)
FDA Link
01/2019
1
Programmed Cell Death 1 Receptor
IBA
12/2018
1
Transferases
IBA
12/2018
1
B7-H1 Antigen
IBA
12/2018
1
N-acetyltalosaminuronic acid (NAT)
IBA
11/2018
1
Curcumin
IBA
12/2016
1
Lactoglobulins (beta-Lactoglobulin)
FDA Link
12/2016
1
Aurora Kinase A
IBA
12/2016
1
Biological Factors
IBA
07/2016
Therapy/Procedure
34
Therapeutics
09/2021 - 10/2002
27
Neoadjuvant Therapy
11/2021 - 06/2002
24
Drug Therapy (Chemotherapy)
01/2021 - 06/2002
10
Radiotherapy
10/2018 - 07/2002
6
Segmental Mastectomy (Lumpectomy)
06/2019 - 09/2003
6
Mastectomy (Mammectomy)
01/2013 - 07/2002
3
Adjuvant Chemotherapy
03/2010 - 07/2002
2
Aftercare (After-Treatment)
07/2016 - 11/2002
1
Immunotherapy
01/2019